FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure
This article was originally published in The Rose Sheet
Executive Summary
FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.